全球犬流感疫苗市場：按疫苗類型、按病毒類型、按分銷管道、按地區

Global Canine Influenza Vaccine Market, By Vaccine Type, By Virus Type, By Distribution Channel, By Geography

出版日期: 2024年04月25日 | 出版商:

Coherent Market Insights | 英文 169 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球犬流感疫苗市場規模將達18.057億美元，2024年至2031年年複合成長率為5.1%，2031年將達25.621億美元。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	18.057 億美元
實際資料	2019-2023	預測期	2024-2031
預測2024-2031年年複合成長率：	5.10%	2031年金額預測	25.621 億美元

圖：2024年犬流感疫苗的全球市場佔有率（%），依地區分類

犬流感是由感染犬的流感病毒引起的傳染性呼吸道疾病。其特點是咳嗽、流鼻水和發燒。大多數狗會在兩到三週內康復，但這種疾病對幼犬、老年犬和感染嚴重的狗來說可能是致命的。全球犬流感疫苗市場受到各地區該病毒病例數量不斷增加的推動。人們對該疾病的認知不斷提高，有效疫苗的普及支持市場的成長。然而，缺乏強制疫苗接種以及疫苗生產成本高昂阻礙市場潛力。總體而言，開發新型疫苗的廣泛研究和開發活動為未來幾年的市場擴張提供了機會。

市場動態：

隨著全球犬流感感染率上升，全球犬流感疫苗市場呈現正成長。研究表明，該病毒在北美、亞太和歐洲的多個國家廣泛傳播。為了陪伴而飼養的狗的增加，再加上狗舍、狗展和公園裡的寵物擁擠，促進了疾病的快速傳播。這導致寵物飼主和狗舍對有效預防犬流感疫苗的需求增加。然而，疫苗生產所需的高資本投資以及一些低度開發地區缺乏標準的大規模疫苗接種政策阻礙市場成長。此外，COVID-19大流行導致供應鏈中斷的限制也帶來了短期挑戰。展望未來，隨著政府機構、疫苗開發商和獸醫共同努力傳播對該疾病和疫苗接種價值的認知，新的機會將會出現。

本研究的主要特點

本報告對全球犬流感疫苗市場進行了詳細分析，以2023年為基準年估計了預測期（2024-2031年）的市場規模（百萬美元）和年複合成長率（CAGR%）。
說明了各個細分市場的潛在收益成長機會，並為該市場提供了一系列有吸引力的投資提案。
提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球犬流感疫苗市場的主要企業。
本報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球犬流感疫苗市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
透過用於分析全球犬流感疫苗市場的各種策略矩陣，將促進相關人員的決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	US$ 1,805.7 Mn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	5.10%	2031 Value Projection:	US$ 2,562.1 Mn

Canine influenza, commonly known as dog flu, is a contagious respiratory disease caused by influenza viruses that infect dogs. It is characterized by coughing, nasal discharge, and fever. While most dogs recover within 2-3 weeks, it can be fatal for young, old, or critically ill dogs. The global canine influenza vaccine market is driven by the growing cases of the virus across various regions. Increased awareness about the disease and availability of effective vaccination is supporting the market growth. However, lack of mandatory vaccination policies and high costs associated with vaccine production hampers the market potential. Overall, widespread R&D activities to develop new variants of the vaccine provide opportunities for market expansion in the coming years.

Market Dynamics:

The global canine influenza vaccine market is witnessing a positive growth backed by the rising incidence of dog flu infections globally. As per research studies, the virus is widespread across North America, Asia Pacific, and several European countries. Growing dog ownership for companionship coupled with clustering of pets in kennels, dog shows, and parks aids in rapid transmission of the disease. This has boosted the demand for effective vaccination against canine influenza among pet owners and kennels. However, high capital investment required for vaccine production and lack of standard mass vaccination policies in some underdeveloped regions impedes the market growth. Moreover, constraints in supply chain disruptions due to the COVID-19 pandemic presented short-term challenges. Going forward, collaborative efforts from government agencies, vaccine developers, and veterinary practitioners to spread awareness about the illness and value of inoculation will create new opportunities.

Key Features of the Study:

This report provides an in-depth analysis of the global canine influenza vaccine market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global canine influenza vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study Zoetis Services LLC, Merck & Co., Inc., Covetrus, CSL Limited, and Boehringer Ingelheim Animal Health USA Inc., Elanco
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global canine influenza vaccine market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global canine influenza vaccine market

Detailed Segmentation-

By Vaccine Type:
- Recombinant Vaccines
- Inactivated Vaccines
- Others
By Virus Type:
- H3N8 virus
- H3N2 virus
By Distribution Channel:
- Public
- Private
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Zoetis Services LLC
- Merck & Co., Inc.
- Covetrus
- CSL Limited
- Boehringer Ingelheim Animal Health USA Inc.
- Elanco

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Virus Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Recent Developments
Regulatory Scenario
Manufacturer Revenue
Pricing Analysis
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Canine Influenza Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 impact on the market

5. Global Canine Influenza Vaccine Market, By Vaccine Type, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Recombinant Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Inactivated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Canine Influenza Vaccine Market, By Virus Type, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
H3N8 virus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
H3N2 virus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Canine Influenza Vaccine Market, By Distribution Channel, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Public
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Canine Influenza Vaccine Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Zoetis Services LLC*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Covetrus
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- CSL Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim Animal Health USA Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Elanco
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies